Study Subject Participation Status | AML Clinical Trials
Item
enrolled on calgb acute myeloid leukemia (aml) treatment studies and concurrently enrolled on leukemia tissue bank protocol calgb-9665
boolean
C2348568 (UMLS CUI [1])
C0023467 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
Survivor short-term | Long-Term Survivor
Item
short-term or long-term survivor
boolean
C0206194 (UMLS CUI [1,1])
C0443303 (UMLS CUI [1,2])
C0206193 (UMLS CUI [2])
Bone Marrow Obtained | Peripheral blood Obtained
Item
bone marrow and/or peripheral blood obtained at diagnosis
boolean
C0005953 (UMLS CUI [1,1])
C1301820 (UMLS CUI [1,2])
C0229664 (UMLS CUI [2,1])
C1301820 (UMLS CUI [2,2])
Leukemia Subtype
Item
leukemia is one of the following cytogenetic subtypes:
boolean
C0023418 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
t(8;21)
Item
t(8;21)
boolean
C3897139 (UMLS CUI [1])
Acute Promyelocytic Leukemia
Item
t(15;17)
boolean
C0023487 (UMLS CUI [1])
inv(16)
Item
inv(16)
boolean
C3897144 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.11
Item
see disease characteristics
boolean